But is it correct to apply these multiples from public traded companies to VC projects without illiquidity discounts? EBITDA is an acronym that stands for earnings before interest, Construction Materials (for companies that supply the raw materials for construction) 9.66 One common method is to look at comparable transactions. Hello. 2020 kicked off with an air of positivity. Its interesting to see, despite the sharp correction in EBITDA multiples, that profit-related metrics suffered much more limited losses than their Revenue-based counterparts, just highlighting how much the profitability and soundness of business models are at the top of investors current concerns. This is especially true for innovative high-growth companies, as they often operate in sectors that are still developing and expanding. Our international network of experts cover oil & gas, renewable, mining, agribusiness across 162 Our dedicated Not for Profit team are experts in delivering business and accountancy services to the education, social housing, charity and membership body sectors. This contraction was also evident in the Find out more. ticket sales and merchandise sales on the premises. autism, Residential multiples are ~20% higher than outpatient, Multiples hit historic highs in 2021-2022 driven by military needs related to the Russia-Ukraine war, Space security & space tourism companies are fastest growing, Coming off years of supply shortages, Automotive OEMs are commanding the highest multiples, Record customer acquisition during 2020 & 2021 pushed aviation company multiples ~15% higher than pre-pandemic, but recession effects through Q1 2023 tempered that growth, with multiples now at ~4.5% over 2019 levels, B2B SaaS multiples decreased for $0m-$1m EBITDA companies when interest rates rose in May 22 and again when equity markets declined in late 2022 early 2023, Strong interest in AI, specifically GPT-4 and other advanced LLMs, portends that businesses that make use of machine learning technology will see higher valuation multiples, Smaller B2B SaaS companies may be valued based on Seller Discretionary Income (SDE) rather than EBITDA, but the two are comparable, Biotech companies often arent valued based on EBITDA due to the length of the approval process, high cost of development & binary nature of outcome; risk-adjusted NPV or comparables to similar companies are used, As interest rates rose in Q2 & Q3 2022, PE firms had more limited access to capital, tempering the higher range of multiples commercial insurance firms saw in 2020 & 2021, which had been 40-50% above 2010s levels; however, there is still plenty of M&A opportunity from larger acquirers & PE shops, EBITDA multiples in construction skew low due to non-recurring revenue and high costs, but when automation (e.g. 0000017303 00000 n 0000007603 00000 n
